We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Tumor-Secreted Ligands Induce Fibroblast Behavior

By LabMedica International staff writers
Posted on 07 Nov 2018
Print article
Image: In pancreatic cancers, the fibrous stroma is particularly abundant, making up nearly 90% of the tumor mass (Photo courtesy of Cold Spring Harbor Laboratory).
Image: In pancreatic cancers, the fibrous stroma is particularly abundant, making up nearly 90% of the tumor mass (Photo courtesy of Cold Spring Harbor Laboratory).
Two chemical messengers have been identified that prompt pancreatic tumor-associated fibroblasts to adapt pro- or anti-cancer behavior properties.

Pancreatic ductal adenocarcinoma (PDAC) is poorly responsive to therapies and histologically contains relatively few cancer cells embedded within a dense mixture of extracellular components and noncancerous cells known as the stroma. In pancreatic cancers, this fibrous material is particularly abundant, making up nearly 90% of the tumor mass. Within the stroma, cancer-associated fibroblasts (CAFs) secrete tropic factors and extracellular matrix components, and have been implicated in PDAC progression and chemotherapy resistance.

Investigators at Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, USA) recently identified two distinct CAF subtypes characterized by either cancer promoting inflammatory phenotypes or cancer suppressing myofibroblastic ones. However, the mechanisms underlying their diversity and their roles in PDAC remain unknown.

For the current study, which examined the mechanism controlling fibroblast diversity, the investigators used organoid and mouse models to identify the chemicals TGF-beta and IL-1 as tumor-secreted ligands that promoted CAF heterogeneity.

They reported in the October 26, 2018, online edition of the journal Cancer Discovery that IL-1 induced specific enzyme expression and activation to generate inflammatory CAFs, and demonstrated that TGF-beta antagonized this process by downregulating IL-1R1 expression and promoting differentiation into cancer suppressing myofibroblasts.

"These cells can convert into one another, depending on the cues they get from the microenvironment and from the cancer cells," said first author Dr. Giulia Biffi, a post-doctoral researcher at Cold Spring Harbor Laboratory. "This is potentially useful because, in theory, you can shift the tumor-promoting cells to tumor-restraining, rather than just depleting the tumor-promoting cells. Ultimately, patients may benefit most from a combination of therapies that target both the cancer cells and parts of the microenvironment that support their growth."

Related Links:
Cold Spring Harbor Laboratory

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.